早期精神病不同阶段妄想与幻觉的出现及动态变化
研究基于北美前驱期纵向研究第二版(N=719)和第三版(N=699)以及蒙特利尔精神病预防与早期干预计划首发精神病患者(N=694),评估精神病临床高危水平妄想与幻觉起病时序。三个样本均显示 attenuated/subthreshold 妄想更早于幻觉出现,且缓解后妄想再发更常见;未来需研究驱动这些症状的机制及其诊断治疗价值。
要点
- 三个样本中 attenuated/subthreshold 妄想均比幻觉更早出现,OR 分别为 NAPLS 2=4.09、NAPLS 3=4.14、PEPP z=7.01(p<.001)。
- 仅表现为 attenuated/subthreshold 妄想者比仅表现为幻觉者更常见,OR 分别为 NAPLS 2=5.6、NAPLS 3=11.11、PEPP=42.75。
- 缓解后 attenuated/subthreshold 妄想再发比幻觉再发更常见(ps<.05),幻觉更常先缓解(ps<.001)。
核心结论
- Attenuated/subthreshold 妄想倾向于在 attenuated/subthreshold 幻觉之前出现,并可能在其发展中起作用。
- 未来工作应检验驱动这些症状的机制之间的关系及其对诊断和治疗的效用。
研究设计与样本
- 研究纳入北美前驱期纵向研究第二版(NAPLS 2,N=719)和第三版(NAPLS 3,N=699)参与者,评估精神病临床高危(CHR-P)水平妄想和幻觉起病时机。
- 同时评估蒙特利尔精神病预防与早期干预计划(PEPP-Montréal)首发精神病患者(N=694)的起病前症状模式。
- 症状起病在基线评估时确定,症状模式演变在24个月内检查。
主要发现
- 三个样本中,参与者更可能报告 attenuated/subthreshold 妄想先于 attenuated/subthreshold 幻觉起病(OR:NAPLS 2=4.09;NAPLS 3=4.14;PEPP,z=7.01,p<.001)。
- 参与者更可能仅表现为 attenuated/subthreshold 妄想而非仅表现为 attenuated/subthreshold 幻觉(OR:NAPLS 2=5.6;NAPLS 3=11.11;PEPP=42.75)。
- 缓解后 attenuated/subthreshold 妄想再发比幻觉再发更常见(ps<.05),幻觉更常先缓解(ps<.001)。
- 在两个 CHR-P 样本中,妄想观念评分随 attenuated 幻觉起病而下降(p=.007)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 未来工作应检验驱动这些症状的机制之间的关系及其对诊断和治疗的效用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hallucinations and delusions are often grouped together as positive symptoms of psychosis. However, recent evidence suggests that they may be driven by distinct computational and neural mechanisms. Examining the time course of their emergence may provide insights into the relationship between these underlying mechanisms. METHODS: Participants from the second (N = 719) and third (N = 699) iterations of the North American Prodrome Longitudinal Study (NAPLS 2 and 3) were assessed for timing of clinical high risk for psychosis (CHR-P)-level delusion and hallucination onset. Pre-onset symptom patterns in patients with first-episode psychosis from the Prevention and Early Intervention Program for Psychosis (PEPP-Montréal) (N = 694) were also assessed. Symptom onset was determined at the baseline assessment, and the evolution of symptom patterns was examined over 24 months. RESULTS: In all 3 samples, participants were more likely to report the onset of attenuated/subthreshold delusions prior to attenuated/subthreshold hallucinations (odds ratios [ORs]: NAPLS 2 = 4.09; NAPLS 3 = 4.14; PEPP, z = 7.01, p < .001) and to present with only attenuated/subthreshold delusions compared with only attenuated/subthreshold hallucinations (ORs: NAPLS 2 = 5.6; NAPLS 3 = 11.11; PEPP = 42.75). The reemergence of attenuated/subthreshold delusions after remission was also more common than reemergence of attenuated/subthreshold hallucinations (ps < .05), which more often resolved first (ps < .001). In both CHR-P samples, ratings of delusional ideation decreased with the onset of attenuated hallucinations (p = .007). CONCLUSIONS: Attenuated/subthreshold delusions tend to emerge before attenuated/subthreshold hallucinations and may play a role in their development. Future work should examine the relationship between the mechanisms that drive these symptoms and its utility for diagnosis and treatment.
引用
- Mourgues-Codern C, Benrimoh D, Gandhi J, et al. Emergence and Dynamics of Delusions and Hallucinations Across Stages in Early Psychosis. Biol Psychiatry. 2025. PMID: 40020853. doi:10.1016/j.biopsych.2025.02.891
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。